Urticaria and angioedema: A clinical spectrum

Annals of Allergy, Asthma and Immunology

Volumn 76, Issue 6, 1996, Pages 484-496

  Charlesworth, Ernest N ^a,b  

^a Brenham Clinic Association   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CETIRIZINE; CORTICOSTEROID; DIPHENHYDRAMINE; DOXEPIN; HYDROXYCHLOROQUINE; LORATADINE; METHOTREXATE; SALAZOSULFAPYRIDINE; STANOZOLOL; TERFENADINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANGIONEUROTIC EDEMA; AUTOIMMUNITY; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FOOD ALLERGY; HEART ARRHYTHMIA; HISTOPATHOLOGY; HUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; PUVA; REVIEW; SOMNOLENCE; URTICARIA;

ANGIONEUROTIC EDEMA; DIAGNOSIS, DIFFERENTIAL; HUMANS; URTICARIA;

EID: 0029901631     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1081-1206(10)63267-x     Document Type: Review

References (90)

1. Hellgren L. The prevalence of urticaria in the total population. Acta Allergol 1972;27:236-40.
2. Nizami RM, Baboo MT. Office management of patients with urticaria: an analysis of 215 patients. Ann Allergy 1974:33:78-85.
3. Champion RH, Roberts SO, Carpenter RG, Roger JH. Urticaria and angioedema. A review of 554 patients. Br J Dermatol 1969;81:588-97.
4. Cooper KD. Urticaria and angioedema: diagnosis and evaluation. J Am Acad Dermatol 1991;25:166-76.
5. Monroe EW, Jones HE. Urticaria: an updated review. Arch Dermatol 1977; 113:80-90.
6. Harris A, Twarog FJ, Geha RS. Chronic urticaria in childhood: natural course and etiology. Ann Allergy 1983;51:161-5.
7. Margolis CF, Nisi R. Urticaria in a family practice. J Fam Pract 1985;20: 57-64.
8. Stanley JR. Bullous pemphigoid, cicatricial pemphigoid, and chronic bullous disease of childhood. In: Fitzpatrick TB, Eisen AZ, et al, eds. Dermatology in general medicine. 4th edition. New York: McGraw-Hill, Inc, 1993;615-25.
9. Hadi SM, Barnetson RS, Gawkrodger DJ, et al. Clinical, hislological and immunological studies in 50 patients with bullous pemphigoid. Dermatologica 1988;176:6-17.
10. Katz SI. Dermatitis herpetiformis In: Fitzpatrick TB, Eisen AZ, et al, eds. Dermatology in general medicine, 4th edition. New York: McGraw-Hill, Inc., 1993:636-41.
11. Soter N. The skin in mastocytosis. J Invest Dermatol 1991;96:32S-9S.
12. Astherson RA, D'Cruz D, Stephens JM, et al. Urticarial vasculitis in a connective tissue disease clinic: patterns, presentations and treatment. Sem Arthritis Rheumatism 1991;20:285-96.
13. Orfan NA, Kolski GB, Physical urticarias. Ann Allergy 1993;71:205-15.
14. Casale TB, Sampson HA, Hanifin J, et al. Guide to physical urticaria. J Allergy Clin Immunol 1988;82:758-63.
15. Wanderer AA, Grendel KE, Wasserman SI, et al. Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria. J Allergy Clin Immunol 1986; 78:417-22.
16. Soter NA. Acute and chronic urticaria and angioedema. J Am Acad Dermatol 1991;25:146-54.
17. Tyson CJ, Czrney D. Cold induced urticaria in infectious mononucleosis. Med J Aust 1981;1:33-5.
18. Becker LC. Allergy in systemic lupus erythematous. Johns Hopkins Med J 1973;133:38-44.
19. Glaser J, Wyss-Sonffront WA. Alleged anaphylactic reactions to human gamma globulin. Pediatric 1961;28: 367-76.
20. Juhlin L. Localization and content of histamine in normal and diseased skin. Acta Derm Venereol (Stock) 1967;47: 383-91.
21. Kaplan AP, Horakova Z, Katz S. Assessment of tissue fluid histamine levels in patients with urticaria. J Allergy Clin Immunol 1978;61:350-4.
22. Phanuphak P, Schocket AL, Arroyave CM, Kohler PF. Skin histamine in chronic urticaria. J Allergy Clin Immunol 1980;65:371-5.
23. Kaplan AP, Gray L, Shaff RE, et al. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol 1975;55: 394-402.
24. Bedard PM, Brunet C, Pelletier G, Hebert J. Increased compound 48/80 induced local histamine release from nonlesional skin of patients with chronic urticaria. J Allergy Clin Immunol 1986;78:1121-5.
25. Cohen RW, Rosentreich DL. Discrimination between urticaria-prone and other allergic patients by intradermal skin testing with codeine. J Allergy Clin Immunol 1986;77:802-7.
26. Kern F, Lichtenstein LM. Defective histamine release in chronic urticaria. J Clin Invest 1976;57:1369-77.
27. Deleuran B, Kristensen M, Larsen CG, et al. Increased tryptase in suctionblister fluid from patients with urticaria. Br J Dermatol 1991;125:14-7.
28. Wallengren J, Moller H, Ekman R. Occurrence of substance P, vasoactive intestinal peptide, and calcitonin generelated peptide in dermographism and cold urticaria. Arch Dermatol Res 1987;279:512-5.
29. Hernanz A, Muelas G, Borbujo J. Plasma neuropeptide pattern in acute idiopathic urticaria. Int Arch Allergy Appl Immunol 1989;90:198-200.
30. Michaelsson G, Juhlin L. Urticaria induced by preservatives and by additives in food and drugs. Br J Dermatol 1973;88:525-32.
31. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria with thyroid autoimmunity: a study of 90 patients. J Allergy 1989;84:66-71.
32. Altud P, Blandon R, Wallach PM, Flannery MT. Case report: the spectrum of autoimmune thyroid disease with urticaria. Am J Med Sci 1993; 306:379-80.
33. Gruber BL, Baeza ML, Marchese MJ, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol 1988; 90:213-7.
34. Marone G, Casolaro V, Paganelli R, Quinti I. IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. J Invest Dermatol 1989;93:246-52.
35. Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria: a clinical immunological and histological evaluation. Br J Dermatol 1986;114: 583-90.
36. Charlesworth EN, Hood AF, Soter NA, et al. Cutaneous late-phase response to allergen: mediator release and inflammatory cell infiltration. J Clin Invest 1989;83:1519-26.
37. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med 1993;328:1599-1604.
38. Kauppinen K, Juntunen K, Lanki H. Urticaria in children. Retrospective evaluation and follow-up. Allergy 1984;39:469-72.
39. Sehgal VN, Rege VL. An interrogative study of 158 urticaria patients. Ann Allergy 1973;31:279-83.
40. Lehach JG, Rosenstreich DL. Clinical aspects of chronic urticaria. Clin Rev Allergy 1992;10:281-301.
41. Goodman DL, McDonnell JT, Nelson HS, et al. Chronic urticaria exacerbated by antioxidant food preservatives, butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT). J Allergy Clin Immunol 1990;86: 570-5.
42. Caballero T, Garcia-Ara C, Pascual C, et al. Urticaria induced by caffeine. J Invest Allergol Clin Immunol 1993; 3(3): 160-2.
43. Belchi-Hernandez J, Florido-Lopez F, Estrada-Rodriguez JL, et al. Sulfiteinduced urticaria. Ann Allergy 1993; 71:230-2.
44. Abeck D, Traenckner I, Steinkraus V, et al. Chronic urticaria due to nickel intake. Acta Derm Venereol (Stockh) 1993;73:438-9.
45. Geha R, Buckley CE, Greenberger P, et al. Aspartame is no more likely than placebo to cause urticaria/angioedema: results of a multicenter, randomized, double-blind, placebo-controlled, crossover study. J Allergy Clin Immunol 1993;92:513-20.
46. Soter NA. Urticaria and angioedema. In: Fitzpatrick TB, Eisen AZ, et al, eds. Dermatology in general medicine. 4th edition. New York: McGraw-Hill, Inc., 1993;1483-93.
47. Lever WF, Schamburg-Lever G. Histopathology of the skin. 75th ed. Philadelphia: J B Lippincott Co, 1990: 152-3.
48. Ackerman AB. Histologic diagnosis of inflammatory skin disease. Philadelphia: Lea & Febiger, 1978:180-1.
49. Peters MS, Winkelman RK. Neutrophilic urticaria. Br J Dermatol 1985; 113:25-30.
50. Jones RR, Bhogal B, Dash A, Schifferli J. Urticaria and vasculitis: a continuum of histological and immunopathological changes. Br J Derm 1983;108:695-703.
51. Grattan CE, Boon AP, Winkelmann RK. The pathology of autologous serum skin test response in chronic urticaria resembles IgE-mediated late phase reactions. Int Arch Allergy Appl Immunol 1990;93:198-204.
52. Berg RE, Kantor GR, Bergfeld WF. Urticarial vasculitis. Int J Dermatol 1988;27:468-72.
53. Mehregan DR, Hall MJ, Gibson LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992;26:441-8.
54. Olson JC, Esterly NB. Urticarial vasculitis and Lyme disease. J Am Acad Dermatol 1990;22:1114-6.
55. Berger BW. Erythema chronicum migrans of Lyme disease. Arch Dermatol 1984;120:1017-21.
56. Weary PE, Guerrant JL. Chronic urticaria in association with dermatophytosis. Response to the administration of griseofulvin. Arch Dermatol 1967; 95:400-1.
57. Platts-Mills TA, Fiocco GP, Hayden ML, et al. Serum IgE antibodies to Trichophyton in patients with urticaria, angioedema, asthma, and rhinitis: development of a radioallergosorbent test. J Allergy Clin Immunol 1987;79: 40-5.
58. Yancey KB, Hall RP, Lawley TJ. Pruritic urticarial papules and plaques of pregnancy (PUPPP): clinical experience in twenty-five patients. J Am Acad Dermatol 1984;10:473-80.
59. Shornick JK. Herpes gestationis. J Am Acad Dermatol 1987;17:539-56.
60. Janier M, Bonvalet D, Blanc MF, et al. Chronic urticaria and macroglobulinemia (Schnitzler's syndrome): report of two cases. J Am Acad Dermatol 1989; 20:206-11.
61. Machet L, Vaillant L, Machet MC, et al. Schnitzler's syndrome (urticaria and macroglobulinemia) associated with pseudoxanthoma elasticum. Acta Derm Venereol (Stockh) 1992;72: 22-4.
62. Saurat JH, Schifferli J, Steiger G, et al. Anti-interleukin-1 alpha autoantibodies in humans: characterization, isotype distribution, and receptor-binding inhibition - higher frequency in Schnitzler's syndrome (urticaria and macroglobulinemia). J Allergy Clin Immunol 1991;88:244-56.
63. Berdy SS, Bloch KJ. Schnitzler's syndrome: a broader clinical spectrum, J Allergy Clin Immunol 1991;87: 849-54.
64. Monroe EW. The role of antihistamines in the treatment of chronic urticaria. J Allergy Clin Immunol 1990; 86:662-5.
65. 1 antagonists in the management of the itch of urticarias. Skin Pharmacol 1992;5:21-4.
66. 1-type antihistamines. J Am Acad Dermatol 1991;24:1084-7.
67. 1 antihistamines. Treatment of urticaria and other clinical problems. Dermatol Clin 1993;11:87-95.
68. Monahan BP, Ferguson CL, Killeavy ES, et al. Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
69. Vanden BG, Emanuel MB, Rombaut N. Clinical profile of astemizole: survey of fifty double blind trials. Ann Allergy 1987;58:184-8.
70. 1 antihistamines in treatment. J Am Acad Dermatol 1988;19:842-9.
71. Belaich S, Bruttmann G, DeGreef H, et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990;64:191-4.
72. Kennard CD, Ellis CN. Pharmacologic therapy for urticaria. J Am Acad Dermatol 1991;25:176-89.
73. Soto LD, Falabella R, et al. Estudio multicentrico comparativo entre dos antihistamininecos anti H1,2 en al manejo de dermatosis cronicus pruriginusas. Dermatol Rev Mex 1987;31: 8-14.
74. Juhlin L. Cetirizine in the treatment of chronic urticaria. Clinical Therapeutics 1991;13:81-6.
75. Fadel R, Herpin-Richard N, Rihoux JP, Henocq E. Inhibitory effect of cetirizine HC1 on eosinophil migration in vivo. Clin Allergy 1987;17:373-9.
76. 1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992; 262:964-70.
77. 1 receptors. Mayo Clin Proc 1979;54:669-74.
78. Green SL, Reed CE, Schroeter AL. Double blind cross-over study comparing doxepin with diphenhydramine for the treatment of chronic urticaria. J Am Acad Dermatol 1985;12:669-74.
79. 2 receptor antagonists on the dermagraphic response. Acta Derm Venereol 1983:63:260-2.
80. 2 histamine antagonists on symptomatic dermagraphism. Br J Dermatol 1979;101: 57-61.
81. Harvey RP, Wegs J, Schocket AL, et al. A controlled trial of therapy in chronic urticaria. J Allergy Clin Immunol 1981;68:262-6.
82. Commens CA, Greaves MW. Cimetidine in chronic idiopathic urticaria: a randomized double-blind study. Br J Dermatol 1978;99:675-9.
83. 2 antagonists: a cross over double-blind long-term study. Z Hautkr 1983;58: 785-93.
84. Brestel EP, Thrush LB. The treatment of glucocorticosteroid-dependent chronic urticaria with stanozolol. J Allergy Clin Immunol 1988;82:265-9.
85. Jaffer AM. Sulfasalazine in the treatment of corticosteroid-dependent chronic idiopathic urticaria. J Allergy Clin Immunol 1991;88:964-5.
86. Stack PS. Methotrexale for urticarial vasculitis. Ann Allergy 1994;72:36-8.
87. Wiles JC, Hansen RC, Lynch PJ. Urticarial vasculitis treated with colchicine. J Allergy Clin Immunol 1984;73: 600-3.
88. Werni RM, Schwartz TH, Gschnait F. Colchicine treatment of urticarial vasculitis. Dermatologica 1986;172: 36-40.
89. Matthews CN, Saihan EM, Warin RP. Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone. Br J Dermatol 1978;99:455-7.
90. Grattan CE, Francis DM, Slater NG, et al. Plasmapheresis for severe, unremitting, chronic urticaria. Lancet 1992; 339:1078-80.